logo

Health News

Share
cdc obesity 091820New data from the Centers for Disease Control and Prevention, or CDC, show that adult obesity is increasing in the United States, and obese individuals are at heightened risk for severe outcomes from COVID-19. The phenomenon remains high in 12 states, according to the 2019 Adult Obesity Prevalence Maps.
Read More

Aurora Cannabis Inc. said Monday that activist investor Nelson Peltz has resigned as a senior advisor to the company, effective September 25, 2020. The Canadian cannabis company disclosed Peltz's resignation while announcing details about its annual general meeting to be held on November 12, 2020. "…280...
Read More
maternalhildhealth sept23 The U.S. Department of Health and Human Services (HHS) has announced financial support of $360 million towards maternal and child health in the country. Out of this, $341 million was allocated to 55 states, territories and nonprofit organizations through the Maternal, Infant and Early Childhood Home Visiting (MIECHV) Program, and $16 million to the State Maternal Health Innovation (State MHI) Pro Read More
fdaaprovedim sep19 07jul20

FDA Issues Emergency Use Authorization To Becton, Dickinson's Covid-19 Antigen Test



The U.S. Food and Drug Administration issued Emergency Use Authorization (EUA) for a new rapid, SARS-CoV-2 antigen diagnostic test. This test can be administered at the point of care that will deliver results within 15 minutes.
Read More
salmonella july22Centers for Disease Control and Prevention and the U.S. Food and Drug Administration are investigating an outbreak of Salmonella Newport infections in 15 states affecting about 125 people.
Read More
Follow RTT


FDA Calendar
Event DateSymbolDrug NameEvent Name
12/27/20MYLMYL-1402O (BLA)FDA decision on MYL-1402O, a proposed biosimilar to Avastin
12/26/20UROVVibegron (NDA)FDA decision on Vibegron for the treatment of overactive bladder
12/20/20AZN.L, AZNRoxadustat (NDA)FDA decision on Roxadustat for the treatment of anemia of chronic kidney disease (CKD), in both non-dialysis-dependent and dialysis-dependent patients
12/20/20MYOVRelugolix (NDA)FDA decision on once-daily, oral Relugolix for the treatment of men with advanced prostate cancer
12/20/20FGENRoxadustat (NDA)FDA decision on Roxadustat for the treatment of anemia of chronic kidney disease (CKD), in both non-dialysis-dependent and dialysis-dependent patients
12/19/20AMGNABP 798 (BLA)FDA decision on ABP 798 (biosimilar rituximab) for Non-Hodgkin's lymphoma and Rheumatoid arthritis
View All